| 000 | 01600 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513234613.0 | ||
| 264 | 0 | _c20010426 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWei, L | |
| 245 | 0 | 0 |
_aTyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. _h[electronic resource] |
| 260 |
_bCancer research _cMar 2001 |
||
| 300 |
_a2439-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xenzymology |
| 650 | 0 | 4 |
_aAnoikis _xphysiology |
| 650 | 0 | 4 |
_aCell Adhesion _xphysiology |
| 650 | 0 | 4 |
_aCell Survival _xphysiology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xphysiology |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTyrosine _xmetabolism |
| 700 | 1 | _aYang, Y | |
| 700 | 1 | _aYu, Q | |
| 773 | 0 |
_tCancer research _gvol. 61 _gno. 6 _gp. 2439-44 |
|
| 999 |
_c11224405 _d11224405 |
||